Sanjay Subramanian

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Malvern, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Sanjay Subramanian
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Sanjay Subramanian

Form 4 holding SVP, CFO & Head of BD

Inozyme Pharma, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$171,325
Report date
01 Jul 2025
Price
$4.45
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Ocugen, Inc.

Security class
Common Stock
Shares / value
161,125
Estimated value
$105,215
Report date
03 Jan 2022
Price
$0.6530
Ownership
Direct
Form 4 holding Chief Financial Officer

Ocugen, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
454,007
Estimated value
Report date
03 Jan 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Ocugen, Inc.

Security class
Option(Right toBuy)
Shares / value
71,120
Estimated value
Report date
16 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP, CFO & Head of BD

Inozyme Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
01 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Sanjay Subramanian

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .